InflaRx NV buy Guggenheim
Start price
26.03.25
/
50%
€1.21
Target price
26.03.26
€9.27
Performance (%)
-32.56%
Price
20.03.26
€0.82
This prediction will end soon
Summary
This prediction is currently active. The BUY prediction by Guggenheim for InflaRx NV is performing very badly with a performance of -32.56%. This prediction currently runs until 26.03.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| InflaRx NV | -1.687% | -1.687% |
| iShares Core DAX® | -4.932% | -11.977% |
| iShares Nasdaq 100 | -2.634% | -2.218% |
| iShares Nikkei 225® | -4.733% | -10.900% |
| iShares S&P 500 | -2.544% | -3.540% |
Comments by Guggenheim for this prediction
In the thread InflaRx NV diskutieren
InflaRx (NASDAQ: IFRX) had its price target raised by analysts at Guggenheim from $7.00 to $10.00. They now have a "buy" rating on the stock.
Ratings data for IFRX provided by MarketBeat